MiMedx Group, Inc reported Q2 EPS of $0.07, versus $0.05 last year. This was in-line with Capital IQ estimates. Revenue for the quarter came in at $76.4 million, versus $57.3 million last year and ahead of the $74.2 million Capital IQ estimate. The company said it sees Q3 revenue in the range of $79 million to $80 million. The Street is at $76.2 million.
For the full year, the company is guiding for revenue in the range of $309 million to $311 million and adjusted EPS in the range of $0.31 to $0.33. This compares to prior guidance of revenue of $303.5 million – $307 million and adjusted EPS of $0.31 – $0.33, and beats the Street view for revenue of $304.7 million and EPS of $0.32.